Freedberg KA - Search Results

1

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. Goldie SJ, et al. Among authors: freedberg ka. Ann Intern Med. 1999 Jan 19;130(2):97-107. doi: 10.7326/0003-4819-130-2-199901190-00003. Ann Intern Med. 1999. PMID: 10068381

2

Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Freedberg KA, Tosteson AN, Cotton DJ, Goldman L. Freedberg KA, et al. J Gen Intern Med. 1992 May-Jun;7(3):261-72. doi: 10.1007/BF02598081. J Gen Intern Med. 1992. PMID: 1351940 Review.

3

The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.

Bergquist SR, Felson DT, Prashker MJ, Freedberg KA. Bergquist SR, et al. Among authors: freedberg ka. Arthritis Rheum. 1995 Mar;38(3):326-33. doi: 10.1002/art.1780380306. Arthritis Rheum. 1995. PMID: 7880186

4

Management of childhood lead poisoning: clinical impact and cost-effectiveness.

Glotzer DE, Freedberg KA, Bauchner H. Glotzer DE, et al. Among authors: freedberg ka. Med Decis Making. 1995 Jan-Mar;15(1):13-24. doi: 10.1177/0272989X9501500104. Med Decis Making. 1995. PMID: 7898292

5

Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.

Freedberg KA, Hardy WD, Holzman RS, Tosteson AN, Craven DE. Freedberg KA, et al. Med Decis Making. 1996 Jan-Mar;16(1):29-35. doi: 10.1177/0272989X9601600110. Med Decis Making. 1996. PMID: 8717596

6

Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis.

Freedberg KA, Cohen CJ, Barber TW. Freedberg KA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):275-82. doi: 10.1097/00042560-199708010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9292586

7

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

Scharfstein JA, Paltiel AD, Freedberg KA. Scharfstein JA, et al. Among authors: freedberg ka. Med Decis Making. 1997 Oct-Dec;17(4):373-81. doi: 10.1177/0272989X9701700402. Med Decis Making. 1997. PMID: 9343795

8

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD. Freedberg KA, et al. JAMA. 1998 Jan 14;279(2):130-6. doi: 10.1001/jama.279.2.130. JAMA. 1998. PMID: 9440663

9

Trillion virion delay: time from testing positive for HIV to presentation for primary care.

Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, Sullivan L, Levenson SM, Hingson R. Samet JH, et al. Among authors: freedberg ka. Arch Intern Med. 1998 Apr 13;158(7):734-40. doi: 10.1001/archinte.158.7.734. Arch Intern Med. 1998. PMID: 9554679

10

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection.

Paltiel AD, Scharfstein JA, Seage GR 3rd, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. Paltiel AD, et al. Among authors: freedberg ka. Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S93-105. doi: 10.1177/0272989X98018002S11. Med Decis Making. 1998. PMID: 9566470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters